<DOC>
	<DOCNO>NCT01310686</DOCNO>
	<brief_summary>To obtain genotypic analysis patient chronic exudative age-related macular degeneration note subretinal intraretinal edema despite continuous monthly Anti-VEGF therapy .</brief_summary>
	<brief_title>Genetics Study Wet Age-Related Macular Degeneration ( AMD ) Non-Responders Vascular Endothelial Growth Factor ( VEGF ) Therapy</brief_title>
	<detailed_description />
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Endothelial Growth Factors</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<mesh_term>Mitogens</mesh_term>
	<criteria>Ability provide write informed consent participation study Subjects diagnose neovascular AMD monthly antiVEGF regimen ( &gt; 10 ranibizumab and/or bevacizumab injection within last year ) still intraretinal subretinal fluid confirm Investigator Subjects Pigment Epithelial Detachment Exclusively Subjects Serous Pigment Epithelial Detachments Subjects history follow : idiopathic polypoidal choroidal vasculopathy pathologic degenerative myopia central serous chorioretinopathy familial drusen adult onset foveal pattern dystrophy</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>wet AMD anti-VEGF</keyword>
	<keyword>Genetic analysis patient Wet AMD respond fully anti-VEGF treatment</keyword>
</DOC>